Form 8-K - Current report:
SEC Accession No. 0001641172-25-014545
Filing Date
2025-06-10
Accepted
2025-06-10 17:00:39
Documents
12
Period of Report
2025-06-02
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43540
  Complete submission text file 0001641172-25-014545.txt   212581

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mgrx-20250602.xsd EX-101.SCH 3032
3 XBRL LABEL FILE mgrx-20250602_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE mgrx-20250602_pre.xml EX-101.PRE 22370
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3848
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 251037889
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)